Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/24852
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Matamoros Grande, Tania | - |
dc.contributor.author | Nevot, María | - |
dc.contributor.author | Martínez, Miguel Ángel | - |
dc.contributor.author | Menéndez-Arias, Luis | - |
dc.date.accessioned | 2010-05-28T17:47:49Z | - |
dc.date.available | 2010-05-28T17:47:49Z | - |
dc.date.issued | 2009-11-20 | - |
dc.identifier.citation | The Journal of Biological Chemistry Vol. 284, No. 47, pp. 32792–32802 (2009) | en_US |
dc.identifier.issn | 0021-9258 | - |
dc.identifier.uri | http://hdl.handle.net/10261/24852 | - |
dc.description.abstract | Val75 of HIV-1 reverse transcriptase (RT) plays a role in positioning the template nucleotide +1, during the formation of the ternary complex. Mutations such as V75M and V75A emerge in patients infected with HIV-1 group M-subtype B and group O variants, after failing treatment with stavudine (d4T) and other nucleoside RT inhibitors. V75I is an accessory mutation of the Q151M multi-drug resistance complex of HIV-1 RT, and is rarely associated with thymidine analogue resistance mutations (TAMs). In vitro, it confers resistance to acyclovir. TAMs confer resistance to zidovudine (AZT) and d4T by increasing the rate of ATPmediated excision of the terminal nucleotide monophosphate (primer unblocking). In a wild-type HIV-1 group O RT sequence context, V75A and V75M conferred increased excision activity on d4T-terminated primers, in the presence of pyrophosphate (PPi). In contrast, V75I decreased the PPi-mediated unblocking efficiency on AZT and d4T-terminated primers, in different sequence contexts (i.e. wild-type group M-subtype B or group O RTs). Interestingly, in the sequence context of an excision-proficient RT (i.e., M41L/A62V/T69SSS/K70R/T215Y), the introduction of V75I led to a significant decrease of its ATP-dependent excision activity on AZT-, d4T-, and acyclovirterminated primers. The excision rate of d4T-monophosphate in the presence of ATP 3.2 mM was about 10 times higher for M41L/A62V/T69SSS/K70R/T215Y than for the mutant M41L/A62V/T69SSS/K70R/- V75I/T215Y RT. The antagonistic effect of V75I with TAMs was further demonstrated in phenotypic assays. Recombinant HIV-1 containing the M41L/A62V/T69SSS/- K70R/V75I/T215Y RT showed 18.3- and 1.5-fold increased susceptibility to AZT and d4T, respectively, in comparison with virus containing the M41L/A62V/T69SSS/- K70R/T215Y RT. | en_US |
dc.description.sponsorship | This work was supported by Spanish Ministry of Science and Innovation Grant BIO2007/60319, Fundacio´n para la Investigacio´n y Prevencio´n del SIDA en Espan˜ a (FIPSE) Grant 36771/08, the Fondo de Investigacio´n Sanitaria (through “Red Tema´tica de Investigacio´n Cooperativa en SIDA” Grant RD06/0006), and an institutional grant from the Fundacio´n Ramo´n Areces. This work was also supported by Spanish Ministry of Science and Innovation Grants BFU2006/01066 and PI07/0098 (to M. A. M.) | en_US |
dc.format.extent | 154379 bytes | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | en_US |
dc.publisher | American Society for Biochemistry and Molecular Biology | en_US |
dc.rights | openAccess | en_US |
dc.subject | HIV-1 reverse transcriptase (RT) | en_US |
dc.subject | thymidine analogue resistance mutations (TAMs) | en_US |
dc.title | Thymidine Analogue Resistance Suppression By V75i Of Hiv-1 Reverse Transcriptase: Effects Of Substituting Valine 75 On Stavudine Excision And Discrimination. | en_US |
dc.type | artículo | en_US |
dc.identifier.doi | 10.1074/jbc.M109.038885 | - |
dc.description.peerreviewed | Peer reviewed | en_US |
dc.relation.publisherversion | http://dx.doi.org/10.1074/jbc.M109.038885 | en_US |
dc.contributor.funder | Ministerio de Ciencia e Innovación (España) | - |
dc.contributor.funder | Fundación para la Investigación y la Prevención del Sida en España | - |
dc.contributor.funder | Instituto de Salud Carlos III | - |
dc.contributor.funder | Fundación Ramón Areces | - |
dc.identifier.funder | http://dx.doi.org/10.13039/501100004837 | es_ES |
dc.identifier.funder | http://dx.doi.org/10.13039/501100007671 | es_ES |
dc.identifier.funder | http://dx.doi.org/10.13039/100008054 | es_ES |
dc.identifier.funder | http://dx.doi.org/10.13039/501100004587 | es_ES |
dc.identifier.pmid | 19801659 | - |
dc.type.coar | http://purl.org/coar/resource_type/c_6501 | es_ES |
item.openairetype | artículo | - |
item.grantfulltext | open | - |
item.cerifentitytype | Publications | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.fulltext | With Fulltext | - |
item.languageiso639-1 | en | - |
Aparece en las colecciones: | (CBM) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
LMenéndez_JBC_32792.pdf | 150,76 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
9
checked on 19-mar-2024
SCOPUSTM
Citations
14
checked on 15-abr-2024
WEB OF SCIENCETM
Citations
13
checked on 24-feb-2024
Page view(s)
282
checked on 19-abr-2024
Download(s)
214
checked on 19-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
Artículos relacionados:
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.